• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Infect Dis J - Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-Based Outbreaks in the 2014-2015 S

tetano

Editor, Senior Moderator
Pediatr Infect Dis J. 2016 Nov 28. [Epub ahead of print]
[h=1]Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-Based Outbreaks in the 2014-2015 Season in Beijing, China.[/h] Zhang L[SUP]1[/SUP], Yang P, Thompson MG, Pan Y, Ma C, Wu S, Sun Y, Zhang M, Duan W, Wang Q.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Little is known about VE against non-medically attended A(H3N2) influenza illness during 2014-2015 when the vaccine component appeared to be a poor match with circulating strains.
[h=4]METHODS:[/h] Forty-three eligible school influenza outbreaks in Beijing, China from November 1 to December 31, 2014 were included in this study. The VE of 2014-2015 trivalent inactivated influenza vaccine (IIV3) was assessed in preventing laboratory-confirmed influenza among school-age children through a case-control design, using asymptomatic controls. Influenza vaccination was documented from a vaccination registry. VE was estimated adjusting for age group, sex, rural vs. urban area, body mass index, chronic conditions, onset week and schools through a mixed effects logistic regression model.
[h=4]RESULTS:[/h] The average coverage rate of 2014-2015 IIV3 among students across the 43 schools was 47.6%. The fully adjusted VE of 2014-2015 IIV3 against laboratory-confirmed influenza was 38% (95% CI: 12% to 57%). Receipt of previous season's (2013-2014) IIV3 significantly modified VE of the 2014-2015 IIV3; children who received both 2013-2014 and 2014-2015 vaccinations had VE of 29% (95% CI: -8% to 53%) while VE for children who received 2014-2015 IIV3 only was 54% (95% CI: 8% to 77%).
[h=4]CONCLUSIONS:[/h] VE for 2014-2015 IIV3 against A (H3N2) illness identified in schools was modest. Children who did not receive the prior season's vaccine with a homologous A (H3N2) component may have enjoyed greater protection than repeated vaccinees.


PMID: 27902651 DOI: 10.1097/INF.0000000000001434
[PubMed - as supplied by publisher]
 
Back
Top Bottom